Media Summary: The team in the Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins has developed and is currently testing a bold ... Dr. Elsa Anagnostou, a CRI Clinical Investigator at Johns Hopkins University, is exploring how Stacey Cohen, MD, University of Washington, Seatlle, WA, provides an overview of the

Using Circulating Tumor Dna Ctdna - Detailed Analysis & Overview

The team in the Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins has developed and is currently testing a bold ... Dr. Elsa Anagnostou, a CRI Clinical Investigator at Johns Hopkins University, is exploring how Stacey Cohen, MD, University of Washington, Seatlle, WA, provides an overview of the Jasmine Zain, MD, City of Hope, Duarte, CA, discusses ongoing research investigating the clinical utility of As part of our bold ambition of one day eliminating cancer as a cause of death, we work Dr Naomi Dempsey, MD from Miami Cancer Institute comments on the

In this video, Ash Alizadeh, MD, PhD, Stanford Comprehensive Cancer Center, Stanford, CA, comments on the I'm Jeanne Tie, here at ASCO 2016, presenting the results of my study, "The potential of ... Bethesda, MD, comments on the remaining challenges facing the widespread

Photo Gallery

Using circulating tumor DNA (ctDNA) for the early detection of cancer.
Circulating Tumor DNA (ctDNA) and liquid biopsy
What is Circulating Tumor DNA (ctDNA)?
Immunotherapy Minute: Circulating Tumor DNA with CRI Clinical Investigator Dr. Elsa Anagnostou
The Doctor Connect : What is Circulating Tumor DNA (ctDNA)
Real-world monitoring of circulating tumor DNA to predict cancer recurrence
The clinical use of circulating tumor DNA in T-cell lymphomas
Ask a Scientist: Circulating Tumor DNA (ctDNA)
Circulating Tumor DNA (ctDNA) in Breast Cancer: 2023 COEDS Ft Lauderdale Conference
Using circulating tumor DNA in lymphoma: clinical trials & clinical practice
Circulating Tumor DNA (ctDNA) to Reshape Clinical Trial Design in Early Stage Cancers
Moffitt Medical Minute - Circulating Tumor DNA (ep. 9)
Sponsored
Sponsored
View Detailed Profile
Using circulating tumor DNA (ctDNA) for the early detection of cancer.

Using circulating tumor DNA (ctDNA) for the early detection of cancer.

The team in the Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins has developed and is currently testing a bold ...

Circulating Tumor DNA (ctDNA) and liquid biopsy

Circulating Tumor DNA (ctDNA) and liquid biopsy

Dr. Benjamin Weinberg explains

Sponsored
What is Circulating Tumor DNA (ctDNA)?

What is Circulating Tumor DNA (ctDNA)?

For more info, visit: https://www.primrmed.com/cancer/general

Immunotherapy Minute: Circulating Tumor DNA with CRI Clinical Investigator Dr. Elsa Anagnostou

Immunotherapy Minute: Circulating Tumor DNA with CRI Clinical Investigator Dr. Elsa Anagnostou

Dr. Elsa Anagnostou, a CRI Clinical Investigator at Johns Hopkins University, is exploring how

The Doctor Connect : What is Circulating Tumor DNA (ctDNA)

The Doctor Connect : What is Circulating Tumor DNA (ctDNA)

One of the CHALLENGES in

Sponsored
Real-world monitoring of circulating tumor DNA to predict cancer recurrence

Real-world monitoring of circulating tumor DNA to predict cancer recurrence

Stacey Cohen, MD, University of Washington, Seatlle, WA, provides an overview of the

The clinical use of circulating tumor DNA in T-cell lymphomas

The clinical use of circulating tumor DNA in T-cell lymphomas

Jasmine Zain, MD, City of Hope, Duarte, CA, discusses ongoing research investigating the clinical utility of

Ask a Scientist: Circulating Tumor DNA (ctDNA)

Ask a Scientist: Circulating Tumor DNA (ctDNA)

As part of our bold ambition of one day eliminating cancer as a cause of death, we work

Circulating Tumor DNA (ctDNA) in Breast Cancer: 2023 COEDS Ft Lauderdale Conference

Circulating Tumor DNA (ctDNA) in Breast Cancer: 2023 COEDS Ft Lauderdale Conference

Dr Naomi Dempsey, MD from Miami Cancer Institute comments on the

Using circulating tumor DNA in lymphoma: clinical trials & clinical practice

Using circulating tumor DNA in lymphoma: clinical trials & clinical practice

In this video, Ash Alizadeh, MD, PhD, Stanford Comprehensive Cancer Center, Stanford, CA, comments on the

Circulating Tumor DNA (ctDNA) to Reshape Clinical Trial Design in Early Stage Cancers

Circulating Tumor DNA (ctDNA) to Reshape Clinical Trial Design in Early Stage Cancers

I'm Jeanne Tie, here at ASCO 2016, presenting the results of my study, "The potential of

Moffitt Medical Minute - Circulating Tumor DNA (ep. 9)

Moffitt Medical Minute - Circulating Tumor DNA (ep. 9)

Today we're going to be talking about

The remaining hurdles for using ctDNA in lymphoma

The remaining hurdles for using ctDNA in lymphoma

... Bethesda, MD, comments on the remaining challenges facing the widespread